- Report
- August 2025
Global
From €4429EUR$4,950USD£3,788GBP
- Report
- June 2025
- 106 Pages
Global
From €3087EUR$3,450USD£2,640GBP
- Report
- June 2025
- 88 Pages
North America
From €3087EUR$3,450USD£2,640GBP
- Report
- June 2025
- 77 Pages
Japan
From €2192EUR$2,450USD£1,875GBP
- Report
- May 2025
- 120 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- February 2025
- 135 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- August 2024
- 116 Pages
Global
From €4026EUR$4,500USD£3,443GBP
- Report
- March 2024
- 78 Pages
Global
From €4429EUR$4,950USD£3,788GBP
- Report
- February 2024
- 75 Pages
Global
From €4429EUR$4,950USD£3,788GBP
- Report
- November 2023
- 78 Pages
Global
From €2192EUR$2,450USD£1,875GBP
- Report
- July 2023
- 55 Pages
Global
From €2192EUR$2,450USD£1,875GBP
- Report
- November 2022
- 154 Pages
Global
From €4474EUR$5,000USD£3,826GBP
- Report
- June 2020
- 464 Pages
Global
From €4384EUR$4,900USD£3,749GBP
- Report
- January 2026
- 160 Pages
Global
From €2827EUR$3,160USD£2,418GBP
€3534EUR$3,950USD£3,022GBP
- Report
- February 2026
- 90 Pages
Global
From €3500EUR$4,190USD£3,098GBP
- Report
- November 2025
- 90 Pages
Global
From €3500EUR$4,190USD£3,098GBP
- Report
- May 2024
- 130 Pages
Global
From €3500EUR$4,190USD£3,098GBP
- Report
- October 2023
- 92 Pages
Global
From €3500EUR$4,190USD£3,098GBP
- Report
- May 2022
- 100 Pages
Global
From €3500EUR$4,190USD£3,098GBP

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient.
Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more